Transplant in Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous  transplant...

Full description

Bibliographic Details
Main Authors: Guilherme Duffles, Carmino De Souza
Format: Article
Language:English
Published: Associação Brasileira de Transplante de Órgãos 2022-06-01
Series:Brazilian Journal of Transplantation
Subjects:
Online Access:https://bjt.emnuvens.com.br/revista/article/view/445
_version_ 1828764026789691392
author Guilherme Duffles
Carmino De Souza
author_facet Guilherme Duffles
Carmino De Souza
author_sort Guilherme Duffles
collection DOAJ
description Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous  transplant uses the patient stem cell for rescue after high-dose myeloablative chemotherapy, while allogenic transplant relies on a different stem cell for a graft-versus-lymphoma effect. With distinct toxicity and capacity to induce remission, those therapies have great value in the management of patients with relapsed and refractory diffuse large B-cell lymphoma.
first_indexed 2024-12-11T02:12:00Z
format Article
id doaj.art-4ead3e8000d94b92b7ffcc9cd5558d87
institution Directory Open Access Journal
issn 2764-1589
language English
last_indexed 2024-12-11T02:12:00Z
publishDate 2022-06-01
publisher Associação Brasileira de Transplante de Órgãos
record_format Article
series Brazilian Journal of Transplantation
spelling doaj.art-4ead3e8000d94b92b7ffcc9cd5558d872022-12-22T01:24:15ZengAssociação Brasileira de Transplante de ÓrgãosBrazilian Journal of Transplantation2764-15892022-06-01252Transplant in Diffuse Large B-Cell LymphomaGuilherme Duffles0Carmino De Souza1Universidade Estadual de Campinas – Faculdade de Ciências Médicas – Hematology and Hemotherapy Center, Campinas (SP), Brazil.Universidade Estadual de Campinas – Faculdade de Ciências Médicas – Hematology and Hemotherapy Center, Campinas (SP), Brazil. Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous  transplant uses the patient stem cell for rescue after high-dose myeloablative chemotherapy, while allogenic transplant relies on a different stem cell for a graft-versus-lymphoma effect. With distinct toxicity and capacity to induce remission, those therapies have great value in the management of patients with relapsed and refractory diffuse large B-cell lymphoma. https://bjt.emnuvens.com.br/revista/article/view/445LynphomaTransplantation, AutologousTransplantation, Allogenic
spellingShingle Guilherme Duffles
Carmino De Souza
Transplant in Diffuse Large B-Cell Lymphoma
Brazilian Journal of Transplantation
Lynphoma
Transplantation, Autologous
Transplantation, Allogenic
title Transplant in Diffuse Large B-Cell Lymphoma
title_full Transplant in Diffuse Large B-Cell Lymphoma
title_fullStr Transplant in Diffuse Large B-Cell Lymphoma
title_full_unstemmed Transplant in Diffuse Large B-Cell Lymphoma
title_short Transplant in Diffuse Large B-Cell Lymphoma
title_sort transplant in diffuse large b cell lymphoma
topic Lynphoma
Transplantation, Autologous
Transplantation, Allogenic
url https://bjt.emnuvens.com.br/revista/article/view/445
work_keys_str_mv AT guilhermeduffles transplantindiffuselargebcelllymphoma
AT carminodesouza transplantindiffuselargebcelllymphoma